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SUMMARY 
Guinea-pigs were immunized with different cells infected with vaccinia virus, herpes 
simplex virus type 1, herpesvirus saimiri, and the virus of vesicular stomatitis. 
Development of cellular immunity against these viruses was observed with 
transformation of blood and spleen lymphocytes and with the migration in-
hibition test using peritoneal exudate cells. Cellular immunity against vaccinia 
virus was first seen 6 days after the inoculation of cell-bound vaccinia virus by 
Iymphocyte transformation. 
The activation of the vaccinia virus specific cellular immune response could be 
induced with tissue cuIture cells as soon as 3 hr after their infection with vaccinia 
virus. Since infectious virus particles are not synthesized within this time period, 
it is likely that virus-induced antigens in the cell surface are active in production of 
cellular immunity. 
Vaccines from heterologous host cells were more effective inducers of an 
immune response than syngeneic cell cuItures. For in vitro testing of cellular 
immunity to viruses, viral antigens could be used in both infective and inactivated 
form. Delayed hypersensitivity to viral antigens was always accompanied by 
immune reactions to the host cells used for virus propagation. 
INTRODUCTION 
Usually viral infections induce the production of humoral antibodies, whose neutralizing 
activity can be shown by in vitro examination. Neutralization of viruses by specific anti viral 
antibodies plays a special role as a protective mechanism in virus infections like poliomyelitis. 
In this disease the degree of immunity can be tested by titrating the antibody response 
(Bodian, 1952). However, in some other virus infections the titre of neutralizing antibodies 
cannot serve as a standard of virus-specific immunity (AlIison, 1966; Blanden, 1970). 
In these infections cell-mediated immunity (CMI) seems to play an essential role. Delayed 
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type immunity can be checked by skin test reactivity. There are also in vitro assays which 
can be used for testing of CMI, for example lymphocyte transformation and the migration 
inhibition test (George & Vaughan, 1962). These two tests seem to be suitable to test CMI 
for insoluble, soluble and viral antigens (David et al., 1964, Rosenberg et al., 1972a). 
We were interested in correlating these methods, for the preparation of infectious and in-
activated viral antigens suitable for sensitization and in vitro testing. Furthermore we in-
vestigated the influence of the cell species used for virus propagation on the course of 
immunization and the accompanying immune reaction to these host cells. 
MATERIALS AND METHODS 
Cell cultures, virus propagation and virus titration 
Cell cultures were grown and maintained in Eagle's minimum essential medium supple-
mented with 15% inactivated calf serum, 100 units of penicillin/mI and streptomycin 
(100 Jlg/ml). Calculation ofTCID50/ml were performed according to the method of Reed & 
Muench (1938). 
Virus were propagated as follows. 
Virus strain Propagated on: TCID50/ml in the 
preparations used 
for immunization 
Vaccinia Permanent monkey 106 . 5 
kidney cells (Vero) 
Permanent baby hamster 
kidney cell (BHK) 
Primary rabbit kidney 
cells (RK) 
Primary embryonal guinea-
pig fibroblasts (GPF) 
Herpes simplex NMRI mice brain 105 . 3 
Type 1 BHK 
Vero 
Vesicular Primary owl monkey 106 . 5 
stomatitis virus, kidney cells (OMK) 
strain Indiana BHK 
Vero 
Herpesvirus saimiri* OMK 105 . 0 
* Herpesvirus saimiri virus was obtained by Professor Dr R. Laufs, Hygiene-Institut, 
Göttingen. 
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Antigens and sensitization 
The infected cell cultures and the aseptically removed tissue material were disrupted by 
three cycles of freezing and thawing. The protein content of the homogenates was equi-
librated to 1 mg/mI (Lowry et al., 1951) with Eagle's medium. After titration of virus 
infectivity the homogenates were intramuscularily injected into guinea-pigs. The animals, 
weighing between 300 and 400 g, were immunized three times with an interval of 3 days 
between each injection and again 1 week after the last injection. One week later the animals 
were bled. In experiments to measure the primary immune response only one injection was 
performed. The volume of the first injection was 6 ml, the following times always 3 ml. 
The results from four guinea-pigs were pooled for every experiment. 
Formalin inactivation 
Virus inactivation was performed by addition of 1 : 4000 diluted formaldehyde solutions 
(Merck number 4003 Darmstadt) at 37°C for 24 hr. After the incubation the formalin was 
bound by sodium pyrosulphide in an equimolar concentration. Decrease of infectivity was 
tested on Vero cells at 4-hr intervals. 
Inhibition 0/ virus growth by interferon 
Interferon (kindly supplied by Dr G. Neumann, Hygiene-Institut, Göttingen) was 
produced in human lymphocytes using Sendai virus as inducer. Test tubes containing Vero 
cells were inoculated with arithmetic dilutions of interferon to assay the antiviral activity. 
After 24 hr stationary incubation the monolayers were washed with Eagle's medium 
and superinfected with 100 TCIDso/ml VSV. The interferon activity was read when cyto-
pathic effects could be seen in control tubes without interferon. The titre of an interferon 
preparation was the highest dilution in which a 50% inhibition of cytopathic effects was 
obtained. Interferon was incubated with a titre of I : 64 for 60 min at a temperature of 37°C 
with OMK cells, grown in Roux flasks. Incubation was continued for 24 hr after adding a 
5-fold volume of tissue culture medium. VSV (100 TCID/soml) was added and after 2 hr 
adsorption washed twice with medium. After aperiod of 36 hr the incubation at 37°C of 
the tissue culture was stopped by repeated freezing and thawing. The antigens for sensitiz-
ation were prepared as described above . 
. Peritoneal macrophage migration 
Five days after the last antigen injection the animals received 20 ml of 3% thioglycolate 
i.p. The test was performed in a modification of the method of David & David (1971). 
The animals were bled 48 hr later by heart puncture. Twenty millilitres of Hanks's balanced 
salt solution (HBSS) supplemented with 50 u of heparin (Thrombovetren, Promonta) 
were injected intraperitoneally and the peritoneal cells were aseptically removed. The 
cells were packed by centrifugation and washed three times in HBSS containing 5% 
homologous serum. After 1: 10 dilution in culture medium, containing TCM 199 with 15% 
homologous, kaolin-absorbed, inactivated serum, 100 u of penicillin and 100/lg of strepto-
mycin, the cells were incubated at 37°C with 20% antigen (1 mg protein/ml). 
After 1 hr ofincubation small capillary tubes (1,2 mm, inside diameter) were filled with the 
cell suspension, sealed at one end and after centrifugation at 25 g for 5 min the tubes were 
cut at the cell-fluid interface. The cell-containing portions were mounted with silicon grease 
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in leucocyte migration chambers (Greiner, Nürtingen, number 25S). After filling with 
medium containing 10% antigen, the chambers were closed with greased cover glasses. 
Twenty-four hours later the areas of migration were projected on plain paper, cut out and 
weighed. The results were expressed as percentage migration. The migration of virus-free 
controls was taken as 100% migration. Every assay for every animal was run in triplicate. 
Chambers with antigen-free medium and chambers containing medium with non-infected 
tissue cell antigen acted as controls. Nonspecific effects were excluded by testing the cells 
from an unsensitized animal in every investigation. The infectious virus cell homogenate and 
the tissue antigen control used for investigation had no migration inhibitory activity on 
unsensitized peritoneal cells. 
The percentage of migration of antigen-incubated cell cultures was calculated as [(migration 
in medium containing virus infected cells)/(migration in medium containing uninfected 
cells used for propagation of test antigen)] x 100. 
Lymphocyte transformation 
Blood was aseptically removed by heart puncture and 25 u of heparin/mI were added 
The erythrocytes were sedimented for 45 min by the addition of 1 ml of 5% Dextran 
(molecular weight 250,000, Pharmacia, Uppsala) to 9 ml of blood and incubation at 37°C 
in tubes held at an angle of 45°. The cells in the supernatant were washed twice in HBSS 
containing 2% homologous serum and 5 u of heparin and then suspended in the same 
culture medium as were the peritoneal exudate cells, in a concentration of 1 x 106 cells/ml. 
In the preparation of spleen lymphocytes the spleens were aseptically removed, cut with 
scissors and cell suspension obtained by repeated pipetting. The cells were then suspended 
in culture medium containing 30% homologous serum. After 1 hr of sedimentation at 4°C 
the phase containing single cells was withdrawn and after washing in HBSS the cells were 
suspended in the same culture medium as the blood lymphocytes. Tests were carried out 
by the addition ofO·2 ml amounts of: (a) viral antigen; (b) non-infective tissue homogenate 
from cells used for the propagation of the sensitizing viral material; (c) non-infective tissue 
homogenate from cells used for the propagation of viral material used for the in vitro 
tests, to I-mI amounts of lymphocyte suspension in plastic tubes (number 160 S, Greiner, 
Nürtingen). All these antigens were of equal protein content (l mg/mI). Other controls were 
set up with tissue culture medium alone. Further controls with phytohaemagglutinin 
(Wellcome) were run to test the ability of stimulating cells in vitro. The tubes were closed with . 
loose caps and incubated at 37°C for 5 days in an atmosphere of 5% CO2 in air. Every 
culture was set up at least in triplicate. S, 
Twelve hours before the stopping of cultures 1·5 /lCi of [3H]thymidine (specific activity 
23 mCi/mmol, Radiochemicals Amersham, Buchler, Braunschweig) was added to every 
tube. DNA extraction was performed after the cultures were terminated (Havemann, 1969). 
Incorporation of radioactivity was counted in a liquid scintillation spectrometer (Packard, 
Model 3380) and calculated as disintegrations per minute (d/min) or as a transformation 
ratio (ratio of incorporation in antigen-transformed cultures to control cultures). 
RESULTS 
Induction of cellular immunity to viral antigens 
Sensitization of guinea-pigs with vaccinia, VSV and herpesvirus saimiri resulted in cell-
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FIG. 1. Comparison of lymphocyte transformation with migration inhibition of the guinea-
pigs injected with vaccinia virus, virus ofvesicular stomatitis and herpesvirus saimiri. Vaccinia 
virus and VSV used for sensitization were propagated in BHK cells, herpesvirus saimiri in 
OMK cells. Antigens for in vitra testing were propagated, if possible, in different host cells, 
vaccinia in Vero cells, VSV in OMK cells, herpesvirus saimiri in OMK cells, (.) Virus-
infected cells. (0) Uninfected cell controls. The columns show the transformation ratio 
(TR) or percentage migration inhibition (MI) of cells from animals injected with vaccinia 
virus, VSV or herpesvirus saimiri. Controls were run with animals injected only with medium; 
the depicted results with vaccinia are representative for all viruses used in this experiment. 
TADLE 1. Specificity of in vitra stimulation of immune lymphocytes by vesicular stomatitis 
virus and vaccinia virus 
Antigens used for 
in vitra transformation· 
(TCID5o/ml 106 '5) 
VSV 
Vaccinia 
Vero cell control 
[3H]thymidine transformation of [3H]thymidine transformation of 
lymphocytes from guinea- lymphocytes from guinea-
pigs immunized with vsvt pigs immunized with vaccinia 
Uptake (d/min) Ratio±s.d. 
1864 
496 
539 
N6±0'33 
0·92±0·22 
Uptake (d/rnin) Ratio± s.d. 
656 
2256 
721 
0'90±0'36 
3'13±0'88 
• Virus antigens used for in vitra test were propagated on Vero cells, while immunization was 
performed with virus material, which was grown on BHK cells. 
t Lymphocytes were obtained from four guinea-pigs in each group 7 days after immuniz-
ation, the values are the mean of three assays with at least triplicate cultures per animal for 
each antigen. 
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mediated immunity, as shown by lymphocyte transformation and migration inhibition. 
Both tests showed a good correlation of the results. The immune reaction was virus-specific 
and cross-reactions between different viruses were not observed (Fig. I, Table I). After a 
single injection of viral antigens the lymphocyte transformation test and migration in-
hibition test were performed every 3rd day post-inoculation. Specific cellular immune 
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FIG. 2. Relationship of Iymphocyte transformation to migration inhibition after sensitizing 
with vaccinia virus. Thirty-two guinea-pigs were injected intramuscularly with 6 ml of vaccinia 
virus TCID5o/ml 106 - 5 propagated on BHK cells. Virus propagated in Vero cells was used 
for in vitro testing. In 3- or 4-day intervals animals were killed and transformation with 
peripheral blood Iymphocytes (e) and spleen Iymphocytes (0) as weil as migration inhibition 
tests (0) with peritoneal exudate cells were performed. 
reactions could be demonstrated in lymphocyte transformation 6 days after the application 
of vaccinia virus, while significant migration inhibition was first seen 10 days later (Fig. 2). 
Infectious tissue homogenates of vaccinia virus were used as antigen for the lymphocyte 
transformation test and for the migration inhibition test and compared with formalin-
inactivated vaccinia virus. Both the non-inactivated and the inactivated vaccinia virus 
gave the same results. In the comparison of formaldehyde-inactivated herpes simplex virus 
(HSV) to live HSV the results were different. While inactivated HSV gave only positive 
results with lymphocytes from HSV-immunized guinea-pigs, the live HSV also stimulated 
lymphocytes derived from animals not sensitized with HSV. Active and inactivated herpes-
virus saimiri gave positive results only with lymphocytes of animals injected with herpes-
virus saimiri (Table 2). 
The relationship between the induction of cellular immunity and the duration of virus 
replication in tissue culture was investigated. Lymphocyte transformation and migration 
inhibition test could be correlated, showing that cellular immunity to vaccinia virus can be 
induced by tissue cultures infected with vaccinia virus for 3-4 hr (Fig. 3). During this period 
of time there is no production of new virus partic1es. Production of complete new virus is not 
necessary to induce cellular antiviral immunity. However, the production of viral antigens 
by the infected cells is aprerequisite for the induction of a virus-specific cellular immune 
response. When the propagation of VSV on OMK cells was inhibited by interferon, the 
interferon-treated tissue cultures could not induce VSV-specific cellular immunity. As was 
expected, cellular immunity to VSV developed only in the animals that had been immunized 
with VSV-infected, non-interferon-treated cell cultures (Table 3). 
Cellular immunity to DNA and RNA viruses 
TABLE 2. In vitra reactions of cell-mediated immunity after immunization with 
different viruses. Virus specificity and actions of viral and inactivated vaccines on 
lymphocyte transformation and migration inhibition 
Transformation ratio (± s.d.) of 
Antigen used for: lymphocytes from: Percentage 
migration 
Immunization In vitra test Spleen Blood inhibition 
Vaccinia Vaccinia (BHK) n.t. 6·95±0·71 20 
(Vero) Vaccinia (BHK) S'43± 1'50 n.t. 55 
(formalin-
inactivated) 
HSV (BHK) n.t. 9'75±0'7S 2 
HSV (BHK) n.t. 1·08±0·32 +4 
(formalin-
inactivated) 
BHK cell antigen 1'01 ±0'22 1·25±0·14 
HSV HSV (BHK) n.t. 5-83±0'95 24 
(Vero) HSV (BHK) n.t. S·43±2·07 72 
(formalin-
inactivated) 
HV saimiri (OMK) 1·27 ±0·33 0'56±0'16 
HV saimiri (OMK) 1'50±0'76 1·26±0·32 n.t. 
(Tween-ether-
inactivated) 
BHK cell antigen 0·S3±0·21 1·44±0·35 n.t. 
HV saimiri HV saimiri (OMK) n.t. 6·63±2·73 n.t. 
(OMK) HV saimiri (OMK) 1·65±0·42 2'72± 1·20 n.t. 
(Tween-ether-
inactivated) 
OMK cell antigen 0·73±0·29 1'42±0'64 25 
HSV (BHK) 6'79±0'44 n.t. n.t. 
HSV (BHK) 0·93±0·34 n.t. 6 
(formalin-
inactivated) 
n.t.=Not tested. 
Importance of the host cell for in vitro antiviral immune reactions 
149 
Vaccinia virus was propagated in vitro in Vero, BHK, RK and GPF cells and in vivo 
in NMRI mice brain. After sensitization of guinea-pigs with these infected cells, in vitro 
tests were performed. Viral antigens used for sensitization and for in vitro tests were propaga-
ted in host cells different from those used for the antigen propagation which were used for 
animal inoculation. Non-infected tissue cultures served as controls. In both tests strong 
immune responses were observed after sensitization with viral antigens grown on hetero-
logous host cells. Propagation in isologous cells induced weak in vitro reactions (Table 4). 
Simultaneously with cellular immunity to viral antigens a clear immune response to the 
host cell antigens, used for the propagation of sensitizing virus, was observed, reaching 
transformation ratios up to 5: 39 (Table 4). 
150 u. Koszinowski and G. Bandlow 
10 50 
c 
2 
.g 8 
~ 
40 :.ö 
:.c 
c::: 
c 6 
.2 
Ö 
E 
.2 4 
30 c 0 
.~ 
'" 20 E 
on 
c 
'" ~ 
I- 2 '" 
0 
10 C 
'" ~
'" Cl. 
o 2 3 4 5 48 
Hours after tissue culture with vaccinia virus 
FIO. 3. Induction of an immune response dependent on time of virus propagation in sensitizing 
tissues. Vero cells were infected with TCID5o/mll03 . 5 vaccinia virus. After 2 hr of adsorption 
monolayers were washed six times with medium. Thereafter no virus was found in the super-
natants. Propagation of virus was stopped at hourly intervals. Logarithmic increase of in-
fective virus in the supernatants began after 10 (10 hr = 101 '5, 20 hr = 102 '5, 30 hr = 103-5 and 
40 hr= 104 .4 TCID5o/rnl). The infected tissue homogenates were injected into different 
groups of animals. Lymphocyte transformation and migration inhibition test to vaccinia virus 
were performed with cells collected 1 week after the last injection. (_) Transformation ratio. 
(0) Percentage migration inhibition. 
TABLE 3. Sensitization of guinea-pigs with VSV-infected cell cultures. Inhibition 
of sensitization by prevention of virus propagation with interferon 
Antigen used for: 
Transformation ratio (± s.d.) 
lymphocytes from: 
Sensitization In vitro test Spleen Blood 
OMK cell control VSV 1'38±0'62 1·25±0·24 
(BHK) 
o MK + interferon VSV H3±0'56 0·95±0·36 
+VSV (BHK) 
OMK + interferon VSV 1'54±0'58 1'69±0'78 
controIs (BHK) 
OMK+VSV VSV 6'24±0'53 5'59± 1·72 
(BHK) 
n.t. = Not tested. 
Percentage 
migration 
inhibition 
+2 
-1 
n.t. 
-22 
Cellular immunity to DNA and RNA viruses 
T ABLE 4. Importance of host cell for in vitro immune response to viral antigens. 
Increased cell-mediated immune response to tissue antigens, in which the sensitizing 
virus had been propagated 
Antigen used for: 
Sensitization 
Vaccinia 
(BHK) 
Vaccinia 
(RK) 
In vitro test 
Vaccinia 
(Vero) 
BHK-cell antigen 
not infected 
Vaccinia 
(VeTO) 
RK-cell antigen 
not infected 
Vaccinia Vaccinia 
(mouse brain) (VeTO) 
Brain-antigen 
not infected 
Vaccinia 
(GPF) 
Vaccinia 
(Vero) 
GPF-cell antigen 
not infected 
Transformation ratio of 
blood Iymphocytes 
X s.d. 
37·51 ± 22·49 
4·20± 1·08 
20·88 ± 12·23 
5·39±4·17 
22·41 ± 14·69 
4·24±2-13 
2·36±0·94 
1·76±0·69 
n.t. = Not tested. 
DISCUSSION 
Percentage 
migration inhibition 
X±s.d 
n.t. 
n.t. 
-22±5 
-19±4 
-32±8 
-35±12 
-14±2 
+8±3 
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Our knowledge of immunity to viral infections in man is substantially based on the determin-
ation of humoral antibodies. The existence of antibodies gives evidence of a former contact 
with viral antigens. Humoral antibodies can serve as markers for immunity. However, the 
immune status is not only dependent on humoral antibodies. Persons with an antibody-
deficient syndrome can resist to some of the viral infections (Good & Varco, 1955), on the 
other hand disturbances of the immune system, which inc1ude impaired CMI, can effect the 
fate of the disease in some of the viral infections (Seligman et al., 1968; Hirsch et al., 
1968; Blanden, 1970; Fulginiti, 1971). This points to the role ofcellular immune mechanisms 
in viral infections. 
Demonstration of cell-mediated immunity by skin reactions is possible (Noren et al., 
1966) but soluble viral antigens used for testing, even after a single cutaneous application, 
can induce virus-specific immune reactions (Rogers et al., 1972). Therefore follow-up 
with in vivo test methods are limited. The investigation of cellular immunity to viral antigens 
in man, by means of in vitro testing, solves this problem. 
There have been investigations with animals on CMI to viruses using migration inhibition 
(Feinstone et al., 1969; Tompkins et al., 1970; Pilchard et al., 1970) and lymphocyte 
transformation (Rosenberg et al., 1972a, b). The T-cell cytotoxicity test was applied to 
demonstrate CMI to mumps virus (Speel et al., 1968), lymphocytic choriomeningitis virus 
(Lundsted, 1969; Marker & Volkert, 1973; Zinkernagel & Doherty, 1974), ektromelia virus 
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(Gardner et al., 1974), leukaemia virus (Profitt et al., 1973; Wright et al., 1973) and sindbis 
virus (McFariand, 1974). 
We could induce cellular immunity to ONA and RNA viruses in guinea-pigs. Lymphocyte 
transformation and migration inhibition correlated very weIl. Induction of cellular immunity 
with vaccinia virus was observed 6 days after sensitization of the guinea-pigs using the 
lymphocyte transformation test. In migration inhibition the first positive reactions were 
found 10 days after injection, this could be due to a different sensitivity of the tests. The 
early peak of lymphocyte response has also been reported by others (Rosenberg et al., 
1972a; Gardner et al., 1974). The early appearance of the maximallymphocyte response, 
as measured in vitro, is followed by diminishing reactivity of the lymphocytes. Therefore 
high and low lymphocyte transformation ratios were observed in the same system with 
varying time intervals. Similar results were obtained by other authors using a modified 
migration inhibition test in rabbits with fibroma virus (Tompkins et al., 1970). By skin 
testing in animals with herpes simplex virus (Rogers et al., 1972) and vaccinia virus (Pilchard 
et al., 1970), positive reactions could be demonstrated beginning 3-4 days after sensitization 
and reaching a maximum within 10 days. We observed that the virus-specific immune 
response of the guinea-pigs was accentuated after using heterologous host cells for the 
propagation of the immunizing virus. 
Ouring the procedure of sensitization to viral antigens the animals also develop an 
immune response to the tissue cell antigens in which the virus has been propagated. The 
immune response to injected tissue cell antigens is more accentuated when the cells are 
infected with vaccinia virus as compared to non-infected cells of equal protein content. 
The viral infection may act as an immunological adjuvant for tissue cell transplantation 
antigens (Bandlow et al., 1972). Therefore viruses for sensitization and for in vitro testing 
should be propagated in different tissues, otherwise an immune response to tissue cell 
antigens may deceive a virus-specific immune reaction. Following such a procedure the 
purification of the test viruses can be omitted. Furthermore in lymphocyte transformation 
with ONA viruses, false positive reactions, caused by viral actions on lymphocytes with 
the incorporation of [3H]thymidine, must be excluded (Bouroncle et al., 1970). In our 
experiments we could observe [3H]thymidine incorporation in lymphocytes of non-immune 
guinea-pigs by using infectious herpes simplex virus as antigen. This can be avoided by 
using inactivated viruses for in vitro testing. On the other hand, inactivation was accom-
panied by a certain loss of the stimulating activity of the virus preparations (Koszinowski 
et al., 1974). Observing these limitations in in vitro reactions, cellular immunity can be 
demonstrated to be virus-specific and not caused by unspecific reactions. 
Cell cultures, in which the propagation of virus was interrupted as early as 3 hr after 
infection, were shown to induce anti viral immunity. Ouring these 3 hr there were no newly 
produced vaccinia virus particles; however, virus-specific antigens can be demonstrated on 
infected cell membranes (Ueda et al., 1972). One could speculate that besides attached 
viral antigens, which are not removed by washing, early viral antigens on the cell surface 
may be equal to or even more effective than complete viral particles in the production of 
CMI to viral antigens. This finding is supported by the fact that viral surface antigens can 
act as an in vivo inducer of skin resistance (Ueda & Tagaya, 1973) and in vitro as antigens in 
the investigation of cellular immunity (Tompkins et al., 1970). However, if virus growth is 
prevented by interferon, cellular immunity to viral antigen cannot be induced. 
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